Try
Vir Biotechnology, Inc.
VIRUnited States
30 filed reports · 400 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
30 reports · Sep 2019 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 4 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 21 | 3,254 | Sep 2019 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 7 | 3,036 | Dec 2019 to Dec 2025 |
| Current · 8-KSEC EDGAR | 2 | 4 | Dec 2021 to Mar 2022 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 5, 2026 | 313 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 7, 2026 | 196 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 23, 2026 | 787 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 5, 2025 | 215 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 6, 2025 | 126 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 8, 2025 | 134 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 27, 2025 | 413 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 4, 2024 | 176 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 1, 2024 | 155 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 3, 2024 | 155 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Feb 26, 2024 | 436 | Open |
| FY2023 Q3 | 10-Q | Sep 30, 2023 | Nov 3, 2023 | 157 | Open |
Financial data
400 concepts · 6,294 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial385 concepts · 5,995 facts · Dec 2017 to Jul 2026
- Money Market Funds47 · Dec 2018 to Mar 2024
- Net income loss43 · Dec 2017 to Jun 2026
- Revenue43 · Dec 2017 to Jun 2026
- Cash and cash equivalents at carrying value42 · Dec 2017 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents42 · Dec 2017 to Jun 2026
- Restricted cash and cash equivalents noncurrent42 · Dec 2017 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value41 · Dec 2017 to Jun 2026
- Allocated share based compensation expense41 · Dec 2017 to Jun 2026
- Comprehensive income net of tax41 · Dec 2017 to Jun 2026
- Depreciation depletion and amortization41 · Dec 2017 to Jun 2026
- Nonoperating income expense41 · Dec 2017 to Jun 2026
- Operating income loss41 · Dec 2017 to Jun 2026
- Other nonoperating income expense41 · Dec 2017 to Jun 2026
- Research and development expense41 · Dec 2017 to Jun 2026
- Stockholders equity (US GAAP)41 · Dec 2017 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect40 · Dec 2017 to Jun 2026
- Increase decrease in accounts payable40 · Dec 2017 to Jun 2026
- Increase decrease in accrued liabilities and other operating liabilities40 · Dec 2017 to Jun 2026
- Increase decrease in other operating assets40 · Dec 2017 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets40 · Dec 2017 to Jun 2026
- Net cash provided by used in financing activities40 · Dec 2017 to Jun 2026
- Net cash provided by used in investing activities40 · Dec 2017 to Jun 2026
- Net cash provided by used in operating activities40 · Dec 2017 to Jun 2026
- Other comprehensive income unrealized holding gain loss on securities arising during period net of tax40 · Sep 2018 to Jun 2026
Product3 concepts · 195 facts · Dec 2017 to Jun 2026
- Revenue167 · Dec 2017 to Jun 2026
- Revenue not from contract with customer25 · Dec 2017 to Mar 2023
- Revenue from contracts with customers (excluding tax)3 · Dec 2023 to Dec 2025
Segment9 concepts · 84 facts · Dec 2022 to Jun 2026
- Reportable Segment14 · Dec 2022 to Jun 2026
- Segment reporting other item amount14 · Dec 2022 to Jun 2026
- Restructuring costs and asset impairment charges12 · Dec 2022 to Jun 2026
- Revenue12 · Dec 2022 to Jun 2026
- Selling general and administrative expense12 · Dec 2022 to Jun 2026
- Net income loss8 · Mar 2024 to Jun 2026
- Cost of revenue (US GAAP)6 · Dec 2022 to Jun 2026
- Profit loss4 · Dec 2022 to Dec 2025
- Cost of revenue2 · Sep 2024 to Sep 2025
Geography2 concepts · 16 facts · Dec 2022 to Jun 2026
- Revenue12 · Dec 2022 to Dec 2025
- U.S.4 · Mar 2025 to Jun 2026
Guidance1 concepts · 4 facts · Feb 2022 to May 2022
- Revenue Guidance4 · Feb 2022 to May 2022
Segments
295 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service10 members · 195 facts
- Grant47 · Dec 2017 to Jun 2026
- Contract Revenue37 · Dec 2017 to Sep 2025
- Collaboration Revenue28 · Dec 2019 to Sep 2025
- Profit Sharing Amount16 · Dec 2021 to Dec 2025
- Profit Sharing Amount Constrained16 · Dec 2021 to Dec 2025
- Profit Sharing Amount Previously Constrained Released15 · Dec 2021 to Dec 2025
- License11 · Dec 2019 to Dec 2022
- License And Collaboration Revenue10 · Dec 2023 to Jun 2026
- License Revenue8 · Dec 2021 to Dec 2024
- Other Revenue7 · Dec 2023 to Jun 2026
Statement business segments1 member · 84 facts
- Reportable84 · Dec 2022 to Jun 2026
Statement geographical2 members · 16 facts
- US14 · Dec 2022 to Mar 2026
- Non Us2 · Jun 2025 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 5, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 17, 2026) and refreshed every few hours.